Aclarion (ACON) has launched a market access program in partnership with PRIA Healthcare.

Financial terms were not disclosed.

The initiative is part of an effort to advance Nociscan, Aclarion's proprietary AI-driven platform for chronic low back pain, through the reimbursement process to expand patient access, the company said.

PRIA will provide payer engagement, prior authorization support and appeals management.